AN ASSESSMENT OF DRUG ADHERENCE ON HIV POSITIVE SECONDARY

SCHOOL STUDENTS AT COMPREHENSIVE CARE CENTRE,KENYATTA

NATIONAL HOSPITAL. by KIAMBI, GERALD M.
  
AN ASSESSMENT OF DRUG ADHERENCE ON HIV POSITIVE SECONDARY 
SCHOOL STUDENTS AT COMPREHENSIVE CARE CENTRE,KENYATTA 
NATIONAL HOSPITAL.  
 
 
 
GERALD M.KIAMBI 
 
 
 
A RESEARCH PROJECT SUBMITTED TO THE SCHOOL OF MANAGEMENT IN 
PARTIAL FULFILLMENT FOR THE REQUIREMENT OF THE AWARD OF THE 
DEGREEOF BACHELOR OF ARTS IN DEVELOPMENT STUDIES OFTHE 
MANAGEMENT UNIVERSITY OF AFRICA 
 
 
 
 
JULY, 2017  
i 
 
DECLARATION 
This research project is my original work and has never been presented in any other university 
for any other award. 
 
 
Signature: ………………………………….Date…………………………….. 
 
GERALD M. KIAMBI 
BDS/9/00059/1/2015 
 
 
Declaration by the supervisor 
This research thesis was prepared and submitted by the candidate for examination with my 
approval as University Supervisor. 
 
 
Signature………………………………….       Date………………………………….. 
Dr. Diana A. Opollo 
The Management University of Africa 
 
  
ii 
 
DEDICATION 
I would like to dedicate this work to my parents and siblings whose dream was to enable me 
realize my desire for highest level of education.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ACKNOWLEDGEMENT 
 
First, with humility and gratitude, I thank and praise God for healthy body, mind and soul 
throughout life especially this study period.I amgreatly indebted to my supervisor Dr. Diana A. 
Opollo, forher unconditional assistance during my study period, preparation and presentation of 
this document. In addition, I cannot forget my family, for their inspiration, moral support and 
patience during my class workseason. Lastly, I accord appreciation to friends, colleagues, 
classmates and the entire Management University of Africa staff fraternityduring class season 
culminating intothis meaningfulproject document. 
 
 
 
 
 
  
iv 
 
ABSTRACT 
Global drug adherence was advocated because non-adherence was documented as the 
commonest reason for treatment failure, potential risk for drug resistance, increased health costs 
or death from opportunistic infections such asTuberculosis, pneumonia and meningitis. Unlike, 
well documented global plagues and holocausts description, HIV/AIDS has two differentials:it 
does not cause rapid death after infection and has affected the young productivecitizens whom 
the economy and family survival depends on. Thus, thorough understanding of determinants of 
adherence to ART was inevitable.TheUN 2030 advocacy policy on ending HIV/AIDS, Kenya 
has expanded national ART coverage tremendously with adults receiving ART increasing from 
55.3% in 2008 to 70.4% in2009. This necessitated theintensity for more ART programs in Kenya 
for successful control, prevention and treatment of HIV/AIDS related morbidity and mortality 
among citizens aged 15 to 64 years.Thus, Kenya’s socio-economic growth and development 
towards vision 2030 blue print is directly affected by nationaldemographic structure, education 
and health status.This retrospective, cross-sectional studyaimed at assessingART drug adherence 
among active Adolescents living with HIV/AIDS atComprehensive Care Centre, Kenyatta 
National Hospital from2ndMay 2016 to 31st July 2017.Participantmedical, clinic attendance and 
pharmacy records were reviewed. A secondary data abstraction questionnaire was used to collect 
demographic data and optimal ART drug adherence indicators categorized as gender, prescribed 
ART regimen, viral load and consistent clinic attendance records from the clinic’selectronic 
Health Management System. The findings were analyzed, presentedin graphs and charts.It was 
observed that there was more male participant (52.7%) than female (47.3%) participants. Male 
participants 35.2 % and female 30.8 % had undetectable viral loads (> 50 copies/mL of blood). A 
recommendation shared with clinic manager was to fast track implementation ofadolescent 
/youth friendly ARTservices in differentiated care approach.  
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ACRONYMS AND ABBREVIATIONS 
HAART  :  Highly Active Antiretroviral Therapy. 
HIV   :  Human Immunodeficiency Virus. 
AIDS   :  Acquired Immunodeficiency Syndrome. 
ART   : Anti-Retroviral Therapy. 
ARV              :           Anti Retro Viral. 
CDC      :          Centre for Disease prevention &Control. 
CCC              :           Comprehensive Care Centre 
KNH     :         Kenyatta National Referral and Teaching Hospital 
FDC     :         Fixed Dose Combination Drugs. 
WTO    : World Trade Organization 
SDG    : Sustainable Development Goals. 
MDG    : Millennium Development Goals. 
MOH               : Ministryof Health 
NASCOP   : National HIV/AIDSand Sexually Transmitted  
Diseases Control Program. 
DOTS    :  Directly Observed Treatment Short course 
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OPERATIONAL DEFINITION OF TERMS. 
Children: These are individuals aged below 15 years from birth(Patateam, 2015). 
Adolescence: it is a consistent period of physical, emotional, mental and physiological 
development for persons aged 10 to 20 years(UN, July, 2016). 
Comprehensive care: the ability of a healthcare worker to offer holistic focused services to a 
patient within an approximate environment i.e. a one stop shop for patients(KAIS, 2013). 
Adherence: this is the ability of a patient to follow and stick on agreed instructions by a 
healthcare professional for a predetermined outcome such as improved patient 
immunity(UNAIDS, 2014). 
Immunity: the ability or power of the body to fight against specific disease causing 
microorganisms circulating in a person’s blood stream or in the tissues(Helen, 2002). 
Viral load: the number of HIV viruses present in a person’s blood stream measured in number 
of copies per millilitre (UNAIDS, 2016).Undetectable viral load is a situation when the HIV 
RNA copies cannot be detectable clinically by standard viral load tests; usually below 50 
copies/millilitre of blood. 
Fixed dose combination: it is a drug preparation method aimed at delivering more than one 
drug into a single formulation, for easier prescription and consumption by a diseased 
patient(Davies, 2013). 
Regimen: it is a cocktail of drugs targeting microorganism especially virus at varied points of 
contact with the host(WHO, 2015).  
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CHAPTER ONE 
INTRODUCTION 
1.0  Introduction 
This chapter entails the background of the study, statement of the problem, objectives of the 
study, research questions, and significance and scope of the study. This was to offer guidance to 
the researcher in conducting the study in accordance with the laid down procedures. 
1.1 Background of the Study 
Global economic growth and development has been defined as the advancement of people's 
socio-economic framework. Unlike growth (short term), development is a process of consistent, 
long-time and sustainable improvement of the social, economic and environmental pillars of a 
society. From an economic perspective, quality education has several direct and indirect 
outcomes such as increased human capital in labour force thus fostering entrepreneurial and 
innovation capacity resulting into higher output equilibrium levels of products and service 
industries as well as transmission of knowledge and skills into people’s livelihoods (Eric & 
Wobmann, 2007). Consequently, the indicators of growth and development include improved 
literacy levels, quality, accessible and affordable health services, improved physical 
infrastructure and adoption of democratic political principles. Moreover, food and socio-
economic security as well as peaceful co-existence of citizenly, aimed at fostering social 
integrity and upholding of universal human rights for sustainablehuman dignity. Therefore, 
public, private and civil society groups and agencies spend massively on prevention, care and 
treatment of diseases in efforts to combat poverty, illiteracy, and poor physical infrastructure.  
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In global and national agenda, such as United Nations (UN), World Trade Organisation (WTO) 
and regional summits, primary healthcare service delivery is a constitutional right 
visiblysignalling stable and secure state. In addition, global Sustainable Development Goals 
(SDGs) global partnerships in research and development have emphasised on basic healthcare, 
especially prevention, care and treatment of HIV/AIDS. A healthy nation is a wealthy nation thus 
inevitably; healthcare and education are fundamental stimuliforsustainablehousehold and 
national cumulative growth and development. 
Advancements in antiretroviral drugs (ARVS) - medications used in combating HIV/AIDS - 
have resulted in precipitous declines in HIV/AIDS associated morbidity and mortality.In USA, 
(Sari, Brandon, Carey, Steven, & Margie, 2009)studies conducted on HIV-infected youth (aged 
13 to 24 years) on adherence to antiretroviral regimens and interventions, was insightful on this 
subject. It proved that within broad contextual youth tailored ART drug 
adherenceinterventions,clear understanding of HIV stigma, disclosure status, caregiver stress, 
peerpressureandrelationships, reproductive health, mental health and substance use as well as 
theindividualattitudeonlong termmedications factors is vital. It also noted that secondary HIV 
prevention measures amongyoung people represent possible modality for delivering individual-
tailored ART medication adherence skills. Thus, offering improvedroutine counseling on 
antiretroviral medication adherence. 
According to the Centers for Disease Control and Prevention (CDC), an estimated 5,259 young 
people aged 13 years to 24 years received HIV /AIDS diagnosisin the United States in 2006, 
(25% increase from estimate diagnosed cases among youth in 2003).The researchers 
demonstrated thatfreedom ofadolescents and young adults living with HIV/AIDS to manage their 
HIV positive lifestylethrough consistentroutine ARVS has caused revolutionofHIV/AIDS into a 
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chronic, rather than imminently life threatening, disease. According to UNAIDS and WHO 
(2001, cited in(Helen, 2002, pp. 19-10), approximately 40 Million adults and children were 
living with HIV/AIDS since  early 1980s and further  5 Million newly infected persons globally. 
Currently, an estimated 36.7 Million people worldwide are living with HIV/AIDS, with 
approximately 52% residing in Sub-Saharan Africa (SSA). HIV has increasingly becomechronic 
managed diseasetriggering global ARVS roll-out efforts to infected persons. HIV/AIDS infected 
persons receivingantiretroviral therapy services (ART), have increased by a third since 2013. 
Observably, in 2015 approximately 17 Million (46%) persons received ART drugs globally. 
Meanwhile, HIV/AIDS comprehensive care and treatment success required sustainable supply of 
ART commodities to health facilities and consistently lifelong counseling sessions on 
importance ofART drug adherence to prescribed treatment regimen(Tessa, Joyce, Sigrid, Susan, 
& Krestin, 2016). Unlike the bubonic plagues of the middle ages in Europe, HIV/AIDS was 
described different in two aspects: first, after initial infection, the body’s immune system can 
fight the virus for longtime hence no rapid illness or death. Secondly, the plagues killed people 
of all ages yet HIV/AIDS primarily infect and affect young and middle aged of whom, the 
economic growth and family survival depend on (Helen, 2002). 
Poor adherence to medication regimens accounts for substantial worsening of disease, death, 
resistance and increased health care costs in the United States. According to Blaschke (2005), of 
all medication-related hospital admissions in the United States, 33 to 69 % are due to poor 
medication adherence, with a resultant cost of approximately $100 billion annually. In treatment 
of people living with HIV/AIDS, it is essential to achieve more than 95 % adherence to highly 
active antiretroviral therapy (HAART) for optimal suppression of viral replication and 
prevention of resistance strains emergence. Achieving such high rates of adherence is very 
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challenging to such patients. In addition, ART drugregimen include multiple, (often expensive)  
medications that have complex dosing schedules, several pills, drugs or food interactions and 
widespread side effects, resulting to poor regimen tolerability and non-adherence to ART 
medication (Stare,2001). 
Drug adherence experienced by HIV positive adolescents was important on improved treatment 
outcomes options resulting in vast number of publications focusing on this subject.World Health 
Organization (WHO) has intensified advocacy on the provision of antiretroviral therapy (ART) 
to reduce Acquired Immune DeficiencySyndrome (AIDS) related deaths and alleviate fears 
about HIV/AIDS. Therefore, global drug adherence has been advocated because non-adherence 
was the commonest reason for ART treatment failure, potential risk for development of drug 
resistance andunnecessary death from resultant opportunistic infections such as pneumonia and 
meningitis. Globally, by 2015 approximately, 10 Million (54%)people living with HIV/AIDS 
were on ARVs resulting into HIV related deaths reduction to below 0.5 Million in all age groups 
(UNAIDS, 2016). Meanwhile, India and China have many people living with HIV/AIDS due to 
high populationwith contrasting lower national disease prevalence(Helen, 2002, p. 8). 
Subsequently, transmission of first-line ART drug resistant strains has increased demand for 
second and third line treatment drug regimen, often associated with poorer patient health 
outcomes and increased healthcare costs. Muchangi, Star Kenya newspaper (2016), reported that 
in sustainability of the gains made in HIV,malaria, tuberculosis and immunization programs, 
Kenya national government health care budget had increased from 47.4  Billion (4% of National 
Budget)in 2014 to a 60.26  Billion in 2017 budget estimates. This has demonstrated efforts to 
retain Millennium Development Goals gains combating HIV/AIDS and re-emergent 
opportunistic diseases including Tuberculosis (TB). 
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In embracing global UN advocacy policy, Kenya expanded its ART coverage tremendously with 
percentage of adults receiving ART increasing from 55.3% (2008) to 70.4% 
(2009).Consequentlythere is need for increasingly intensified ART programs in Kenya for 
successful treatment, control and prevention of HIV-related morbidity and mortality among 15 to 
64 years aged citizens largely affecting country’s economic growth.In accordanceto Kenya Aids 
Indicator Survey (2012), out of the national population of 38 Million, estimated 1.2 Million 
constitutes People Living with HIV/AIDS yielding 5.6 % national HIV infection rate, not 
uniformly distributed within all counties. In response, Kenyan government rolled out freeARVs, 
throughits National Aids & STI Control Program (NASCOP), aimed at lowering HIV-related 
morbidity and mortalities. 
However, studies have shown that drug adherence has remained a clear challenge despite the 
provision of free and accessible quality HIV/AIDS medication and related services.In 2014,  
strategic Kenya HIV prevention revolution road map to vision 2030 by the Ministry of Health 
(MOH), recommended theintegrationand implementation of the UN global policy on 90-90-90 
(test 90% of all contacts, 90% of those found HIV positive, enrolled on ARVS and 90% of these 
should attain optimal viral suppression) to curb the scourge. Meanwhile, Art drug non adherence 
risk factors differ broadly, necessitating context-specific development of individual profiles. This 
was to enable healthcare providers focus on patient - tailored care to avert costly risk of non-
adherence(Wanja, 2016).  
NASCOP (2013) revealed that gender and age constituted factors for sharp non uniform rise in 
HIV prevalence in Kenya counties. It was observed that prevalence among young girls and 
women rose from 2.1 among 15-24 years aged to 10.5% among 25-35 year aged, despite more 
treatment coverage (52% among women to 41% in men). Therefore, adolescents and youth 
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cannot be ignored in the efforts to reverse and end the scourge by 2030. Thus, for optimal socio-
economic growth and development in Sub Saharan Africa (regionbearing global HIV/AIDS 
disease burden of up to 80%), the youthARTdrug uptake and subsequentadherence to 
medication, was vital  for retention on care (UNAIDS, 2014). 
In conclusion, according to Kenya National Bureau of Statistics of 2015, Nairobi County had 
population of 4,232,087 comprising of approximately, 2.0M males (49%) and 2.1M female 
(51%) with children population composition of 34% and 18 % of 15-24 years aged. In addition, 
the county had prevalence of 6.1% of which estimated 7.6% women and 4.7% men, 14% aged 
15-24 years and 5 % children less than 15 years of age, demonstrating HIV/AIDS infection 
vulnerability in females aged more than  25 years in the city. Thus, Nairobi County hadART 
drug coverage of 87% and viral suppression rate of 28 % necessitating intensified HIV testing, 
counseling and linkages to care for maximal viral suppression(NACC, 2016). 
1.1.1 Profile of Comprehensive Care Centre, Kenyatta National Hospital (CCC-KNH). 
Kenyatta National Hospital was established in 1901 as native civil hospital with two ward 
capacity. In 1922 it grew into a 423 bed service facility for Africans and 41 beds for Asian 
communities. In 1952 it was renamed King George VI Hospital throughBritish Protectorate 
Governor’s order. After Kenya’s independence, it was renamed in honor of first President, Mzee 
Jomo Kenyatta and changed its status from a department in the Ministry of Health into a state 
corporation through legal notice no.109.Kenyatta National Hospital maintains its global, regional 
and national status as Centre of excellence in provision of specialized health care services with 
bed capacity of 1800 (50 wards), 209 beds for private wing, 22 outpatient clinic services and 
6000 staff.Its HIV/AIDS Centre of excellent, Comprehensive Care Centre (CCC- KNH) is a 
specialized outpatient clinic managed by a director ofspecial programs in the hospital 
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organogram with collaborative internal and external partners.It has units headed by team leaders 
and 60 staff membership, delivering HIV/AIDS and related healthcare service points of care to 
approximately 10,000 clients (children, adolescents, youths and adults). Currently, CCC-KNH 
mandate includes Teaching and Referral Hospital services in the provision of specialized health 
care, research and developmentto actively participate in National health planning and policy 
formulation. It visualizes an intention to be a world class, patient-centered specialized care 
hospital. 
1.2 Statement of the Problem 
In Kenya, HIV/AIDS was declared nation disaster in 1999 with a preference on children and 
adults in both national policies and service delivery. Thus, for too long, the adolescents have 
been invisible in national plans, policies and budgetary allocations and actual point of care 
targeting that age group. Thisresulted in high HIV/AIDS related cross transmissions, more 
hospitalizations and missed school time due to opportunistic diseases and resultant unnecessary 
death. Recent executive government efforts and presidential declarations on youth agenda, has 
escalated embankment on UN commitment to eliminate this scourge by 2030. Meanwhile, ART 
enrolments for all HIV positively tested persons with no consideration for age, gender and socio-
economic status is ongoing. ARVs have been denoted globally as miracle cocktail of medications 
that have elevated infected people’s survival rates hence longevity of life. Thus, ART drug 
adherence was critical in attaining and maintaining quality lifestyles for infected and affected 
population. Measuring adherence has been highlighted as a complex, expensive and 
unexploitedundertaking in sub Saharan Africa region. Thus an ideal ART drug adherence 
measurement instruments was classified as either direct or indirect for reliability, affordability 
and practicability with low participant and staff burden. Whereas developed countries useddirect 
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sophisticated biological technologies such as blood-drug concentration profiling for drug 
adherence monitoring of patients, developing countries relied on indirect adolescents self-
reporting, Directly Observed Therapy Short course (DOTS) and used clinical evaluation as well 
as pharmacy record methodologies. The authenticity of actual medication consumptions has been 
‘wait and sees’ phenomenon in our Kenyan resource limited settings. Moreover, adolescent age 
group has been demanding, dynamic and dilemma-filled group irrespective of HIV/AIDS status. 
Therefore, adherence to ARV medications for optimal and long term outcomes; undetectable 
viral loads, optimal immunity, quality of life and low scourge transmission, in adolescents and 
youths living with HIV/AIDS remains thorn in the flesh globally. Quality education and 
healthcare services is among the cardinal components of socio-economic growth and 
development. Valid government and civil society reports have demonstrated that high HIV/AIDS 
infection, more opportunistic infections prevalence, high number of disease resistance strains and 
high mortality are a critical aspect in this cohort, for sustainable combat against 
HIV/AIDS.Seemingly, ART drug adherence in adolescents is directly or indirectly affected by 
consistency in clinic attendance for routine checkup and number of prescribed medication. 
Objectively, the study aimed at assessing determinants and outcomes of optimal adherence to 
ART medication among the adolescents. Furthermore, it aimed at establishing the role of gender 
and viral load onART drug adherence among HIV-positive secondary school students attended, 
at Comprehensive Care Centre, Kenyatta National hospital within the previous 15 months.  
1.3  Objectives 
1.3.1  General Objectives 
This study aimed at assessingART drug adherence among HIV positive Secondary School 
students atComprehensive Care Centre, Kenyatta National Hospital. 
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1.3.2  Specific Objectives 
a. To assess the effect of gender on ART adherence among adolescents aged 15 to 20 years 
receiving ART careat CCC-KNH. 
b. To determine the relationship between pill burden among adolescents and ART drug 
adherence. 
c. To assess the role of adolescent viral loadsin optimizing ART drug adherence. 
d. To determine the effect of consistent adolescent clinic attendance on ART drug 
adherence. 
1.4  Research Questions 
i. How does gender influence ART drug adherence in adolescents receiving care at CCC-
KNH? 
ii. To what extent does pill burden affect ART drug adherence in adolescents living with 
HIV/AIDS at the CCC-KNH? 
iii. To what extent does viral load play a role in adolescents ART drug adherence? 
iv. How does consistent scheduled clinic attendance influence ART drug adherence? 
1.5  Significance of the Study 
Adherence to ART medication regimens has been monitored since the time of Hippocrates, when 
the effects of various options were recorded with notations of whether patients had taken them or 
not. 
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1.5.1 Adolescent and Youth 
The study has enabled school going HIV positive adolescentsunderstand the role of status 
disclosure, acceptance and adherence to life-long ART medication.Unlike children and adults, 
adolescents and young adults are mostly excluded from many global and national strategies to 
curb the scourge. Thus, adolescents’ received inadequate support during transition from 
childhood to adulthood and creating gaps in health care service delivery. As they transition into 
education systems, they are expected to take charge of their individual health as well as be 
oriented to their mental predisposition as adults. Thus, they are under self-care, with unforeseen 
issues onstatus disclosure, fear of stigma from routine environment as well as emphasised daily, 
timely, lifelong taking of drugs. This resulted in complex hindrance factors to effective, efficient 
and quality oriented HIV/ AIDS prevention, care &treatment. The was need for continued 
emphasis on routine adolescent ART adherence counselling to influence factors such as  number 
of prescribed drugs, clinic attendance, timely consumption of the medication and viral load 
measurements for optimal ART drug adherence  realisation. 
1.5.2 Researchers 
HIV/AIDS is a chronic disease with a milliard of complexities hence this study has provided 
insights on need for consistent communication and understanding of ARV 
medicationadherenceandincorporation of school support system among adolescents and youth.It 
also aimed at establishing gaps in health care service providers and related stakeholders such as 
secondary school institutions, caregivers and executive policy framework. Measurable adherence 
indicators such as school holiday scheduled clinic attendance, bi-annual viral load, and 
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disclosure status as well as gender factors impacted on adolescent friendly healthcare service 
provision nationally. 
1.5.3 CCC- KNH Management 
With the global efforts to end HIV/AIDS by 2030, locally the programs to combat the scourge 
required consistent partnership inputs with statistical basis in routine service provisions. Thus the 
organisation’s management team has benefitedfrom the information collated in 
demonstratingpractical ARTmedication adherence indicators in active adolescents, within the 
previous 15 months. An adolescent friendly service as well as emphasis on individualised 
differentiated care in long-term disease such as HIV/AIDS was targeted as basis for learning and 
improving treatment, care and prevention of other chronic disease in the cohortgroup. 
1.6 Scope of the Study 
This study aimed at assessing, identifying and summarizing determinants and outcomes of ART 
drug adherence among HIV-positive secondary school studentsat Comprehensive Care Clinic, 
Kenyatta National Hospital (CCC-KNH), in Nairobi County. This retrospective cross sectional 
study considered only active HIV positive adolescents / youth aged 15 to 20within 15 months 
commencing2ndMay2016 to 31st July 2017. In reference to CDC policies, which formbasis for 
NASCOP guidelines, optimal ARTdrug adherence was considered to be acceptable atgreater 
than 95%. This implied that in 30days the participant is expected to miss not more than three 
drug doses. The capability to accurately monitor ART drug adherence andits consequential 
outcome was crucial for retention of participants into beneficial ART care and sustainability. 
  
12 
 
1.7  Chapter Summary 
Despite global achievements in health past the 1950s, more people die of preventable, non-
communicable diseases such as diabetes, cardiovascular, measles, malaria and malnutrition. With 
1980s emergence of HIV/AIDS; immunity compromising disease, healthcare sector has observed 
rapid emergence of curable yet deadly opportunistic infections such tuberculosis, pneumonia, 
malaria and meningitis requiring long-term and costly treatmentas well as resultant unnecessary 
death.  Therefore, ART drug adherence has remained a global challenge and cannot be further 
ignored despite intensified collaborative efforts to scale up provision and access to free and 
quality ARVS medications towardsan HIV/AIDS free generation by 2030. Clearly, Everett 
Koop’s (Blaschke & Lars, 2005), statement that drugs do not work in patients who do not take 
them, capturedthe importance of ARTmedication adherence. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.0  Introductions 
This section involves review of the literature and findings from other studies carried out in the 
past on this related area of study.  It further, involves use of presently availed knowledge, skills 
and experiences as well as industrial reports to assist in reviewing the work from earlier 
researchers on the subject. Theoretical review aims to establish the existing investigative 
literature on ground breaking hypothesis for testing in HIV/AIDS infections. Moreover, 
empirical review show cases knowledge obtained from observed or measured actual experience 
rather than belief. Therefore, this section highlights on past and ongoing studies on adolescent / 
young adult issues that influence adherence to HIV/AIDS medication and their outcomes.  
2.1  Theoretical literature review 
Since the early 1980s discovery of HIV infection in the US, there has been a profound 
engagement in the knowledge and skills to first understand the infection and establish 
methodologies to curb its spread. However, being an immune compromising infection, spread 
mainly through blood and other body fluids from infected persons, HIV/AIDS has grown into a 
public health problem. Globally, the main mode of infection spread has been noted as consented 
or non-consented sexual exposures thus made scholars categorize HIV/AIDS as a sexually 
transmitted disease like gonorrhea and syphilis. However, intensive studies have refuted this 
angle by introducing the subject of vertical mother to child transmission, which has resulted into 
strategies to curb generational spread of HIV/AIDS through prevention of mother to child 
transmission (PMTCT). With intensified research and development efforts, antiretroviral therapy 
(ART) was introduced to objectivity rejuvenate an infected individual’s body immune system 
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despite limited knowledge on drugs side effects, sustainable supply and adversity on long-term 
use. Thus, the global partnerships efforts were incorporated in the 2000-2015 UN Millennium 
Development Goals (MDG) strategy for equitable availability and accessibility of ART services 
to all. Thus, the United State Presidential Emergency Plan for Aids Relief in developing and 
under developed countries (US-PEPFAR), was coined under 43rd US president George W. Bush 
administration and propagated by his successor. 
According to UNAIDS children HIV factsheet (2016), it was observed that 77% of pregnant 
women living with HIV meaning that 3 in every 5, had access to ART in 2015, through 
prevention of mother to child transmission programs (PMTCT). Thus, about 150,000 children 
became HIV positive compared to a high of 490,000 in 2000. However, it stated that only 54% 
of the children exposed to the scourge in 21 highest disease burden countries were tested within 
recommended two months. This was due to inaccessibility to the centralized complex diagnostic 
laboratory technology and long queues waiting for results by post-delivery mothers. Therefore, it 
was clear that the only method to establish HIV/AIDS status of individuals at any age was 
through specific HIV testing and counseling services (HTC), whether voluntarily (VCT) or by 
healthcare provider initiatives (PITC). Consequently, an estimated 1.8 Million children (under 15 
years) were captured as living with HIV/AIDS while only 49% had access to life saving ART 
drugs compared to 21% in 2010. 
Meanwhile, HIV/AIDS was noted as cardinal cause of death among 15 - 19 year olds globally 
and second in Sub-Saharan Africa (SSA). Furthermore, it was approximated that half of 
adolescents living with HIV/AIDS are in just six countries namely South Africa, Mozambique, 
Kenya, Tanzania, Nigeria and India. In addition, 7 in 10 new infections among adolescents in 
SSA are girls due to factors such as non-comprehensive HIV knowledge, early traditional 
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marriage practices, multiple sexual partnerships, and low income earnings in 
households(Patateam, 2015).  
In Kenya, the HIV/AIDS prevalence among adults aged 15 to 64 years has been 5.6% with non-
uniformed distribution pattern in all counties, resulting into a 1.2 Million, representing 6.8% of 
persons living with HIV/AIDS in Sub Sahara Africa. Notably in 2011, the annual new HIV 
infection was as high as 13,510 persons in Nairobi and as low as 10 in Wajir counties. In 
addition, gender and age factors were demonstrated as vital factors in the sharp rise of HIV 
prevalence in Kenya. Thus, prevalence among girls and young women rose from 2.1% among 
15-24 year olds to 10.5% amongst 15-35 year age group. Nationally, two cross sectional based 
surveys were carried out in 2007 and 2012 to monitor HIV epidemic changes, evaluate 
preventive, care and treatment measures for surveillance on national demographic, behavioral 
attitudes and blood specimen’s collections and analysis from 18 months aged babies to 64 years 
aged adults. Conclusions demonstrated that national adult (15-64 years) HIV prevalence 
decreased from 7.2% in KAIS 2007 to 5.6% in 2012 with a 0.9% in children (KAIS, 2013). 
2.1.1 Fixed-dose drug combination theory 
With intensified global scientific and technological advancements into research and development 
division in healthcare provision, morbidity levels have increased significantly. Lifestyle 
disorders such as hypertension and diabetes as well has high mortality in fatal infections such as 
malaria, tuberculosis and immunity compromising disorders mainly HIV/AIDS have required 
multiple classes of medications for optimal short or long term individualized health output. An 
open label randomized control clinical trial to establish the effect of fixed dose combination 
treatment of cardiovascular patient drug adherence in Australia concluded that fixed dose 
combination drug delivery modality was highly acceptable to patients and healthcare 
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practitioners. It was observed that there was significant improvement of 81% in long term 
cardiovascular medication adherence compared to 46% on single medications care(Vanessa, et 
al., 2014). In addition, there wascontinued reformatory agenda in development of efficacious, 
less complex, synergistic drug combinations for easier regulation in manufacturing, optimal cost 
by healthcare service providers and easy administration to the end user for optimal adherence 
benefits (Jeremy & Scotts, 2011). 
In  21st century healthcare evolution, it was observable that successful efforts in combating 
tropical diseases such as Malaria and Tuberculosis, with multiple synergistic medications in 
fixed dose efficacious drug combinations was adopted in management of HIV/AIDS as well as 
its co-morbidities inSub-Saharan Africa. According to Davies (2013), transitioning from 3-
separate Antiretroviral medications into a once a day single (FDC) tablet was beneficial to the 
supply chain management team, prescribers and patients reducing pill burden to guarantee long-
term ART  drug adherence. 
With longevity of life among infected individuals, HIV/AIDS programshave been cornered into 
addressing ART drug adherence in prevention, care and treatment routine protocols. Uguru and 
Eneh (2013) conducted a survey to objectively determine factors affecting adherence to pediatric 
ART in Part Harcourt, Nigeria and observed that barriers to adherence were largely attributable 
to caregivers. It was reported that patient factors such as age, literacy levels, gender of the child, 
type and duration of ART did not significantly affect ART drug adherence. However, itwas 
documented that predictors of good adherence outcomes included disclosure of HIV status, 
regular clinic attendance and self-owed strategy for medication taking remindersin achieving 
minimal forgetfulness. 
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2.1.2 Behavior change theory 
In treatment sustainability of chronic diseases, patient focused status disclosure and mental 
predisposition on healthcare benefits from long-term medication is paramount for successful 
health service provision. Thus, consistent patient focused counseling should be incorporated in 
the establishment of rational human behavior in development and implementation of strategies to 
promote sustained medication adherence. Behavior change theory has been found useful in long 
term Tuberculosis and HIV/AIDS medications use at all age levels (Salla, Simon, Tanya, & 
Jimmy, 2007). 
Behavior is an attribute of routine patient habits focused on intrinsic and extrinsic driving forces 
towards consistent self-awareness, timely clinic appointment that result into better ART drug 
adherence outcome. It was notable that health beliefs, relationship coherence and habit strengths 
played vital roles in adolescent, youth and adult HIV/AIDS treatment goals namely significantly 
sustainable viral suppression, stabilized immunity recovery and elimination of opportunistic 
infections amalgamating into improved individual quality of life(Leigh, 2011). 
The 2014 Kenya National adolescents and youth package of care guidelines initiatives 
significantlyemphasized on strict ART drug adherence for immediate and long term benefits to 
adolescents living with HIV/AIDS. Reproductive health knowledge and skills are some of 
behavior change focused pillars in achievingreduced risk of HIV transmissions and unintended 
pregnancies(NASCOP, 2015). Further to this, multidisciplinary team decisions and multi sector 
approach wasadvocated in the efforts to end HIV/AIDS among adolescents and young 
adults;especially in differentiated patient care service such as PMTCT, infant and children  as 
well as adolescent / youth  friendly services at all primary healthcare service provision  points. 
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According to Ulrike G.Nandra, UNICEF Kenya AIDS program chief, for too long HIV/AIDS 
infected adolescents and youth have been ignored both in planning and policy at national and 
county budgetary allocations, resulting into unexpectedly high HIV related unnecessary deaths. 
The ability to accurately and appropriately monitor and timely address medication adherence was 
highlighted as a national challenge. However, advocacy groups such as Sauti-Skika with 
approximate membership of 1000 youths put hope on the executive government commitments 
such as President Kenyatta’s initiatives on linkage of schools with health facilities with readily 
available and accessible free ART services provisions nationally (Njanja, 2015). 
2.2  Empirical literature review 
In evidence based literature, medication non-adherence is a glowing concern to clinicians, 
healthcare systems and other stakeholders specifically in chronic disease management such as 
diabetes, tuberculosis, hypertension and HIV/AIDS. There is mounting evidence that ART drug 
non-adherence is prevalent and associated with adverse outcomes as well as high healthcare 
costs among household, business and national stakeholders. The objective of this study was to 
assess ART adherence among HIV positive adolescents at Comprehensive Care Centre, Kenyatta 
National Hospital. Objectively, optimal ART medication adherence indicators namely patient pill 
burden, consistent clinic attendance, patient gender and viral load records was scrutinized and 
analyzed. 
2.2.1  Gender and ART drug adherence 
In the children and adolescents 2015 statistical updates, Michel Sidibe (UN executive director) 
emphasized that ending HIV/AIDS epidemic by 2030, was dependent on social justice which 
constituted equity in education, employment and health for both girls and boys empowerment on 
own health choices(Patateam, 2015). For decades HIV/AIDS has continued to be a thorn in flesh 
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of public health sector globally. By 2001 estimates, more than 28.5 Million people were living 
with HIV/AIDS in Africa comprising approximates of 70% of World’s people living with 
HIV/AIDS. According to Helen (2002, pp. 12), from Ethiopia to Botswana countries, one (1) 
person in every ten (10) persons aged 15-49 years, had HIV confirmed infection. Thus, SSA 
population average life expectancy was estimated to have been lowered from 62 years to 47 
years by HIV/AIDS scourge. 
Meanwhile, adolescence is a transitory age marked with rapid developmental, emotional and 
social changes in both girls and boys. Several AIDS fora, have observed that they are 
underserved by HIV/AIDS services globally, resulting into high risk of loss to follow up and low 
ART medication adherence. Notably, several barriers are faced in this age group towards early 
adulthood healthcare service provisions including ethical-legal and policy issues on consent for 
HIV testing and counseling services, enrolment and retention into HIV/AIDS care systems. 
Thus, adolescents living with HIV/AIDS neededequitable, acceptable, accessible, age 
appropriate, effective and durable services to foster social support, retention into care for 
harmonized combat against ART medication non-adherence. Subsequent trade-off between 
infection transmission risks and benefits of early ART initiation, provided by the right person, in 
the right way and to the right person, empowered the emergence of Adolescent Friendly HIV 
healthcare service global centers(WHO, 2015). These are strategies aimed at ensuring that 
adolescents are diagnosed early, timely enrolled into ART medication, and appropriately 
supported for maximal retention into care. 
According to Kedney (2014), United Nations Population Fund estimated that there was global 
young people (10-24 years) demographic surge of approximately 1.8 Billion. The researcher 
demonstrated that this population dividend is culminating into destabilized countries in the 
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region unless political leaders and other global stakeholders work harder and in partnerships to 
secure access to sexual and reproductive health services, education and employment 
opportunities for young people. Further, hestatistically demonstrated that 6 out of 32 low literacy 
leveled countries are in Sub Sahara Africa with a further projection of 60% young people 
population growth by 2030. Thus, with global challenges of universal high quality education, 
unemployment, emerging and re-emerging disease trends in regard to substantial population 
changes in Asia and African continents, HIV/AIDS is critical  in 2030 Sustainable Development 
Goals attainment. UN population (2015, May, p.4) compared trends in population, age structures, 
youth employments, gross domestic products (GDP) and per Capita in Tunisia and Republic of 
Korea. It concluded that there was necessity for informed investment in youth age group for 
optimal realization of next generation of innovators, entrepreneurs; change agents and global 
leaders for utilization of any nation’s demographic dividend mainly in economic growth and 
development agenda. 
A repeated cross sectional survey with unlinked anonymous blood sampling at the antenatal 
clinic in Zambia, aimed at examining social demographic HIV prevalence patterns and trends, 
and demonstrated that HIV/AIDS was highly prevalent in children bearing women. The study 
covered 27 areas in Zambia sampling 11,517 children bearing women within a 2-4 year period. 
Thus, with exception of 15 to 19 years age group, findings demonstrated an exponential trend in 
HIV infection despite increased educational attainment. It was highlighted that urban residing 
women scooped 25 to 35% infection prevalence in comparisonto rural residency at 8 to 16 % 
respectively. It was observed that tendencies of changing social status were a sign of ongoing 
process of significant behavior change in HIV/AIDS combat(Fylkeynes, et al., 1997). 
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Due to biological and anatomical differences between girls and boys, HIV/AIDS has been shown 
to affect more girls than boys. Thus gender in terms of cultural and socio-economic factors 
hasblamed for more girls being HIV infected than boys as well as higher number of non-
adherence trends in adolescent group. Thus Robert Shaffer’s general statement that healthcare 
teams ought to view adolescents not as bottles to be filled but candles to be lit for global 
achievement of an HIV infection free generation by 2030proclaims necessity for holistic 
approach into ART drug adherence. Cheruitich et al (2012) through a study on HIV, sexual 
partnership and behavior among adolescent girls (15-19 years) in Nairobi demonstrated that 
many girls experienced sexual debut compared to same age boys. Thus, they are likely to report 
transactional or non-consensual sexual contact from multiple adult partners annually, risking 
early pregnancies, sexually transmitted diseases (STD) and ultimately HIV infections. 
According to Heesterman, et al (2017), scaling up of ART drug use resulted in higher life 
expectancy hence patients’ medication adherence follow up was paramount subject. The Main 
determinants of non-adherence established in the study included; use of alcohol, male gender 
dominance, use of traditional  and herbal medicine, dissatisfaction with healthcare facility and 
healthcare workers, depression, discrimination and stigmatization, and poor social support. In 
addition, the reviewed findings established promoters of ART drug adherence as consistently age 
appropriate counseling and education interventions, memory aids, and active disclosure among 
people living with HIV for support system.  
2.2.2  Pill burden and ART drug adherence 
Reaching for excellence in Adolescent care and health project (REACH study) enrolled 161 
human adolescent subjects from 13 cities in US to find out ARV medication adherence among 
HIV adolescents infected through sexual contacts and drug injecting abuse modalities. It 
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revealed that 7% could not identify their drugs, 11% missed at least one drug and 83% used 
ARV medications erratically. However, 41% of the sampled adolescents reported full adherence 
to medication. Findings indicated that optimal adherence of above 95% to all medications 
resulted to reduced viral loads and high levels of immune cells above 500 copies per mL of 
blood. In addition a trend was postulated between number of prescribed drugs and optimal ART 
drug adherence. REACH study concluded that strict adherence to HAART was critical for 
sustained viral suppression to ensure immune reconstitution and decreased ART drug resistance 
selection trends for future treatment options (Murphy, Wilson, Dunako, Belzer, & Muenz, 2010). 
In addition ,(McConnell, Robert, Mary, Sharon, & Tamara, 2005) established with clarity that 
the US HIV infected children are aging while using ARVs for extended periods of time. Thus 
HAART has achieved low mortality and higher life expectancies of the seropositive children and 
adolescents into adulthood. It was observed that continued changes in ARV regimen, effective 
modification of ARV formulations in affordably, accessible, quality and fixed dose combinations 
(FDC) resulted into sustainability of the gains achieved.  However, in resource limited settings 
such as SSA, timely supply of high quality and functional ARVs as well as skills, knowledge and 
equipment for timely, intensified and comprehensive testing of ARVs effectiveness on users 
body, was still challenging. Thus, ART drug adverse reactions and opportunistic infections case 
findings were dependent on high index of suspicion of the healthcare workers.  
In linking ART drug adherence to immunological and virological parameters in regard to gender 
and age, a descriptive study by Jobanputra et al (2015) in Swaziland, established that advanced 
disease patients had high viral loads hence less likely to achieve desirable viral undetectable 
levels (< 50 viral copies/mL of blood). They further observed that treatment support tended to 
improve adolescent adherence to both scheduled clinic attendance and medication taking. 
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Therefore, consumption of ARVs was aimed at viral suppression and immune reconstitution 
whose outcome was better quality of life and minimal re-infection rates. Subsequently, number 
of prescribed drugs regimen directly influenced adherence level to medication and resulted into 
vulnerability to selective drug resistance as well as virological failures (Harrigan, Dong, & 
Woodward, 2005, pp. 339-47). 
The National target of 80% HIV testing and counseling was necessary to formulate appropriate 
HIV preventive, care and treatment service. In 2007 it was stated that only 36% of Kenyans 
population had tested for HIV despite 83% willingness for household testing. Moreover, barriers 
such as limited access to the service due to sites distance and limited education were cited. It was 
demonstrated that household HIV testing rates increased with education level; 56.3% for those 
reporting no primary education and 74.3% for those with secondary education or higher (Anne, 
Wanjiru, & Andrea, 1999). Kenya expanded ART coverage tremendously with percentage of 
adults receiving ART increasing from 55.3% in year 2008 to 70.4% in 2009. This consequently 
intensified the need for more ART programs in Kenya for successful control and prevention of 
HIV/AIDS related morbidity and mortality among 15 to 64 years aged citizens. Notably, no 
absolute instrument to measure ART adherence has been developed to holistically be considered 
valid, reliable and logistically practical with low healthcare staff and patient burden. Thus 
complexity of HIV medication has dictated use of more than 3 drugs from at least 2 of readily 
available ART drugs into one prescription. Embracing malaria and tuberculosis program 
initiatives to reduce pill burden, fixed dose drug combinations were developed and sensitized in 
adolescent HIV/AIDS package of care. This was aimed at addressing number of pills taken in 
specified timings of the day by an individual with regard to adolescents schooling schedules.  
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2.2.3 Consistent scheduled clinic attendance and ART drug adherence 
Subs Saharan African region bears burden of social, economic and political factors that directly 
makes its constituents countries vulnerable to emergent life threatening diseases such as malaria, 
tuberculosis and HIV/AIDS. A study conducted in Kayunga district hospital, Uganda 
demonstrated that out of 392 adults prospectively monitored in over 28 weeks on clinic 
attendance, 361 (92%) kept all appointments as an effective measure for optimal medication 
adherence. The findings informed on the conclusion that good medication adherence for durable 
viral suppression entailedappropriately scheduled clinic appointments keeping despite reasons 
such as forgetfulness, economic difficulties on transport fares and diverse caregivers and patients 
travels (Sector, John, & Eric, 2010). 
With rapid initiatives to intensively counsel and test global citizen through the UN 90:90:90 
policies to end HIV/AIDS by 2030, many infected children, adolescents and adults were initiated 
on ART medication with resultant improvement on virological and immunological markers. 
According to NIH (2014), viral loads assessment, aided by consistently, scheduled clinic 
attendance every 3-6 months was mandatory. This was amalgamated into improved survival 
rates and management of HIV/AIDS as other chronic diseases with long-term use of medication 
where pill fatigue was inevitable.  
2.2.4 Viral load and ART drug adherence 
Objectively, the cardinal ART drug adherence goal was to achieve significantly persistent and 
durable viral suppression hence efficient viral load control and immune cell monitoring was 
vital. Research indicated that undetectable Viral load indicatorconstituted HIV-RNA measures of 
20-75 copies in milliliter (mL) of blood, (standardized undetectable viral load of < 50 viral 
copies) achievable within 8-24 weeks of initiation into ART care and treatment. These 
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participants’viral loads reflectedacceptable adherence behavior on appropriately informed, 
selected and prescribed ART medications to the right patient during well-timed clinic attendance 
(NIH, 2014). A study by Nachega et al (2009) to establish the influence of age (11-19 years and 
adult subjects between 1999-2006), virological and immunological indicators on ART drug 
adherence concluded that adolescents in Southern Africa are less adherent (20.7% at 6 months 
and 6.6% at 12 months) to these medication resulting into low rates of immunological recovery 
and erratic viral suppression than adults (40.5 % and 20.6% respectively). In addition, it was 
observed that adolescents achieving 100% adherence within 12 months on ART drugs had 
significantly shorter time of viral rebound than adults. 
Studies continually demonstrated relationship between immune cells and viral loads in people 
living with HIV/AIDS. Recently, it was established that there was significantly consistent 
relationship between gender, immunity cells and viral loads in ART initiated individuals. 
Findings from greater than 30,000 blood samples of people living with HIV in US and 
Netherlands indicated that women had higher viral loads than men when with 50 immune cells 
per mL of blood and lower Viral loads with greater than 350 cells per ML of sample blood 
(Donnelly, et al., 2005).ART drug dose timing was influenced by school schedules, education 
support systems and number of prescribed drugs (ART regimen) resulting into high 
(unsuppressed) viral loads (> 1000 copies/mL) and subsequent changes into second or third line 
ART treatment regimen.  
2.3  Summary and Research gaps 
For decades, HIV/AIDS has continued to be the growing global public health problem 
necessitating multi-sector and multi-disciplinary combative efforts to achieve the desired UN 
2030 HIV/AIDS free generation target. UNAIDS (2016) indicated that ignorance, 
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misunderstandings, discriminatory attitudes and behaviors, facilitated by punitive laws, policies 
and non-committal political executives, continued to undermine effectiveness and efficiency in 
fast track HIV/AIDS free societies. In low income countries especially Kenya bearing population 
of approximately 44M and 6.8% of Gross Domestic Product (GDP) expenditure on healthcare, 
adolescent ART drug adherence assessment wasinevitable. Unlike many chronic diseases such as 
diabetes and hypertension, whose drug regimens remain effective after eminent treatment 
interruptions and resumptions, non-adherence to ART medications was noted as unforgiving 
hence focused prevention of HIV infection and sustainability into ART care was paramount. 
2.4  Conceptual frame work 
Figure 2.1: Diagram showing relationship between theories, dependent and 
independent variables 
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2.5  Operationalization of variables. 
HIV diagnosis, enrolment into long-life ARVs medications, adolescent disclosure status and 
secondary school education support system directly influencedoptimal ART drug adherence. 
Scheduled clinic attendance andnumber of prescribed ART drugswerereviewed in regard to 
laboratory viral load reports of adolescent participant aged 15-20 year within stipulated 15 
months of study. All independent variables were demonstrated to be impactful onoptimally 
acceptable ART medication adherence of greater than 95 %. Therefore, ART drug adherence 
wasmultidimensionalphenomenon whose indicators includedconsistent clinic attendance, number 
of pillsconsumed by participant, viral load measures as well as gender influence on the desirable 
outcome. 
Table 2.5:  Table showing the operationalization of study variables. 
Variable Indicator Reference 
Gender  Male or Female Patient records 
Pill burden  ART treatment regimen Patient records 
Clinic attendance  Scheduled attendance dates Patient records 
Viral loads 
(copies/mL) 
Viral loads lab results Patient records 
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2.6  Chapter summary. 
Adolescence is the bridge age group between children and adults who enjoy self-independence 
on healthcare subject. It is an age where post basic education was aimed at transforming an 
individual into an informed,rational thinker problem solver and decision maker. It is 
characterized by rapid developmental, emotional and social changes where HIV/AIDSadds to the 
complexity. On initiating free ART programs, drug adherence counseling was cardinal for every 
patient / caregiver and reinforced on the subsequent clinic attendance. Longevity of life in 
patients optimally adherent to ART drugs necessitated strategic multi-sector and multi-
disciplinary approach involving all relevant stakeholders to achieve increased advocacy trend on 
differentiated ART care and treatment. Intentional adoption and implementation of 
adolescents’friendly healthcare services concept characterized byequity, accessibility, 
affordability, acceptability and age focused programs was beneficial. Thus post primary school 
adolescentinvolvementimproved optimal ART drug adherence trends, decreased / delayed sexual 
debut and pregnancy rates. In conclusion, lifelong process of appropriate information and 
attitude acquiringfostered self-awareness and life skills attitudes such asself-care, decision 
making, problem solvingand relationships yielding holistic approachin adolescent HIV/AIDS 
care. 
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CHAPTER THREE 
RESEARCH DESIGN AND METHODOLOGY 
3.0 Introduction 
This chapter entails the description of methods applied in carrying out the research study. It was 
organized under the following subsections: research design, target population, sample design and 
instruments use,incorporating ethical consideration on participant privacy protection. It also 
incorporated how data was collected, analyzed and presentedembracing participant information 
confidentiality for authenticity and reliability of output. 
3.1 Research design 
Theresearcher undertook the retrospective cross sectional study on adolescents living with 
HIV/AIDS, aged 15 to 20 years, at CCC- KNH for the previous 15 months commencing on 2nd 
May 2016 to 31th July 2017. This period enabled participants’ assessment within three 
consecutive school holiday scheduled clinic attendance with atleast one viral load laboratory 
report. Thus, participants’ health records were reviewed from the clinic’s electronic management 
system in use. 
3.2 Target population 
According to NACC (2016 pp.148) Nairobi county had 14 % adolescents living with HIV/AIDS. 
Unpublished 2016 report demonstrated that CCC-KNH had 800 adolescentstaking ART drugs. 
For reliability threshold, 91active adolescents recorded into the clinic electronic health 
management system and initiated on ART treatment within the study period dated 2nd May 2016 
to 31st July 2017 and aged 15 to 20 years of age was considered as part of the study population. 
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3.3 Sample and sampling technique 
Using purposeful non probability sampling design, all 91 active adolescents recorded into the 
clinic electronic system aged 15 to 20 years, within the study period of2nd May 2016 to 31st July 
2017 were considered as study participants. 
3.3.1 Inclusion criteria 
All active adolescents aged 15 to 20 years who received adolescent living with HIV/AIDS care 
and recorded into the clinic’s electronic management system within the study period. 
3.3.2 Exclusion criteria 
All adolescents living with HIV/AIDS aged below 15 years or above 20 years or within specified 
age group but have not been initiated on ART treatment within the stated 15 months of study.In 
addition all inactive, transfer out and deceased participants were excluded for consistency, 
reliability and objectivity threshold. 
3.4 Instruments 
The researcher with assistance from designated data clerk used tailored data abstraction 
questionnaire that emphasized on five study components.For objectivity of the study, the 
components considered included age, gender, ART treatment regimen, laboratory viral load 
reports and scheduled appointment. The sample abstraction questionnaire used was attached in 
the appendix for authenticity. 
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No. Components of data abstraction Measurements 
1. Age 15-20 years old 
2. Gender No. of male and female 
3 ART treatment regimen ART drugs prescribed 
4.. Scheduled clinic appointments Attendance dates 
5. Viral loads report Lab Viral copies/mL  
 
3.5  Validity 
Upon submission of the official introduction letter (appendix), researcher accorded authority 
from the clinic manager and an assistance by a designated professional health records staff. He 
explained data abstraction procedure from the clinic’s electronic health management system in 
use into an excel sheet for easier management. The data abstraction questionnaire was observed 
to be objective, accurate and specific on study subject. 
3.5.1 Reliability 
Researcher’s use of accurately obtainedsecondary data on 91 active adolescent participants living 
with HIVfrom the clinic health management electronic system has ensureddata reliability within 
Nairobi County and beyond. 
3.6  Data collection procedure 
With the assistant accorded by designated data clerk, a five-main component data abstraction 
questionnairedesign was adjusted, piloted on digital standard queries from electronic health 
management system in use. It wasapproved and data was collected, cleaned and saved in 
Microsoft excel sheets for easier analysis. The researcher ensured all necessary components were 
captured on by reconfirming the study objectives and research questions.In precision, participant 
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anonymity, privacy and confidentiality was an absolute ethical consideration thus no participant 
bio data was obtained for identity by researcher. 
3.7  Data analysis and presentation 
With assistance from designated data clerk, obtained data was organized and presented in tables, 
charts and graphs to demonstrate relationship between conceptualized valuables in the study 
areaof adolescent ART drug adherence. 
3.8  Ethical considerations 
For privacy and confidentiality of institution participant health record and reports, written 
permission was sought and data clerk assigned by clinic managerin confidence to access and 
obtain only necessary data. This was upon presentation of the official school introductory letter 
for project data collection. On completion of the study, clinic manager was informed of 
researcher’s official termination of data collection period for only academic purpose. 
3.8.1  Informed consent 
In precision, a data abstraction questionnairewas prepared for use during data collection.  
Participants’ names and clinic’s evident serialized unique patient numbers was excluded. 
3.8.2  Voluntary participation 
Participant secondary data was obtained from the clinic electronic health management system in-
use via a simplified highly specific data abstraction questionnaire approved by the clinic 
manager with no direct participant engagement.  
3.8.3  Confidentiality 
Data was obtained from the clinic electronic system, cleaned, analyzed and presented without 
direct encounter with the participant with supervision and assistance by the designated data clerk. 
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3.8.4  Privacy 
The participant data was provided by the authorized healthcare professional with minimal 
participant physical encounter or bio data to fulfill desired academic purpose only. The findings 
were not to be published without written and approved authority from the clinic manager. 
3.8.5  Anonymity 
Participant direct engagement, names and clinic unique serialized identitywas purposefully 
omitted by researcher to ensure anonymity. 
3.9 Chapter summary 
In precision, it was notable that there was emphasized objectivity on collecting authentic data 
and analyzing it through standardized technique to obtain accurate, relevant, valid and reliable 
output. It further demonstrated use of specific research instruments for data collection such as 
specific designed secondary data abstraction procedures. Participants’ dignity and anonymity 
were purposefully protectedfor intended beneficial outputs to all relevant stakeholders. Thus, 
Ethical consideration was inevitable in this study due to sensitivity of the data obtained. 
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CHAPTER FOUR 
INTRODUCTION 
4.0  Introduction 
This chapter gave the data analysis of the study findings which were collected and analyzed by 
the researcher using quantitative and qualitative methods to obtain better understanding of study 
findings and the objectives. The findings were organized and presented into tables, graphs and 
charts for study objectivity. 
4.1  Findings. 
 
4.1.1 How does gender influence ART drug adherence in adolescents receiving care at CCC-
KNH? 
Table 4.1: Table showing gender differentiation of participants 
 
Gender Participant Percentage % 
Male  48 52.7 
Female 43 47.3 
total 91 100 
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Figure 4.1:Diagram showing gender differentiation in ART drug adherence. 
 
 
 
 
Figure 4.1 demonstrated that study participant differentiationon gender basis was 48 male 
accounting for 52.7 % and 43 female representing 47.3% of the study population of 91 (100%) 
participants. According to PataTeam (2015) report, ending HIV/AIDS in sub-Saharan Africa by 
2030 was dependent on gender equity for social justice constituting education, employment and 
health. This pie chart demonstrated 5.4 % difference in gender ART drug access and use in 
adolescents living with HIV/AIDS at CCC-KNH from May 2016 to July 2017.The gender ratio 
of 52.7 % (boys) against 47.3 % (girls) demonstrated need to intensify ART drug access and use 
by the Kenyan adolescent population living with HIV/AIDS to cover the > 5% difference in 
ART drug adherence for a sustainable active population.  
  
Participant Gender Ratio
Male
Female
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4.1.2  To what extent does viral load play a role in adolescent ART adherence? 
Table 4.2: Table showing the participants Viral loads. 
VIRAL LOADS 
Viral loads (copies /mL) Gender Number of participants Percentage (%) 
Un detectable (< 50) Male 32 35.2 
Female 28 30.8 
Suppressed (51- 999) Male 7 7.7 
Female 7 7.7 
Un suppressed (> 1000) Male 8 8.8 
Female 8 8.8 
Without viral loads Male 1 0.1 
 Female 0 0 
Total  91 100 
 
Figure 4.2:Diagram showing the participants Viral loads values. 
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Figure 4.1 demonstrated four participant viral load categorization in both male and female as 
either undetectable (< 50 copies/mL of blood) bearing 32 male (35.2%) and 28 female (30.8 %). 
This category of participant represented66.1% of participants’ diligent beneficiaries of optimal 
adherence to ART drugs.Second category showed that an equal of 7 male and 7 female 
participants had attained viral suppression (<1000 viral copies/mL of blood). This implied that 
ART drugs were achieving their goal of durable viral suppression and subsequently improved 
immunity system.The third category portrayed that an equal ratio of male (8) and female (8) 
participants had unsuppressed high viral loads.It was indicative of poor ART care and treatment 
output and possibility of severe opportunistic infections such as tuberculosis and meningitis. This 
supported the needed intensive individualized adolescent ART drug adherence counseling to 
address underlying factors such as pill burden and poor clinic attendance. In regard to Nachega et 
al (2009) study whose conclusion that adolescents (11-19 years) in southern Africa were non-
adherence to ART drugs resulting into low immunity and unsuppressed viral loads than adults, 
seemed the true in CCC KNH from the findings. The last category showed only a single 
personhad no viral load laboratory results. On further inquirythe researcher was informed of two 
possibilities: the participant had either transferred himself out of the clinic without official 
notification to another center. He might also be experienced ART drugs fatigue and solely 
decided to take unsupervised drug/pill holiday. The designated study data clerk was obligated to 
urgently notify clinic social work team for further individualized follow up and inquiry on this 
participant.He was found fairing physically well and seemingly not under parent or guardian care 
and acknowledged avoiding access to laboratory services but taking ART drugs diligently. 
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4.1.3  To what extent does pill burden affect ART drug adherence in adolescent living with 
HIV/AIDS at the CCC-KNH? 
Table 4.3: Table showing the type of ART drug regimen prescribed 
Participant ART Drug Regimen  
 Drug regimen  Gender Participants  percentage% 
Fixed dose combination (2-drugs) Male 23 25 Female 21 23 
Fixed dose combination (3-drugs) Male 16 18 Female 18 20 
3 or more Single drugs Male 9 10 Female 4 4 
   
Pill burden was the measure of number of drugs pill prescribed and taken as a course of 
treatment by an individual participant. Table 2 indicated that 2-drugs fixed dose combinations 
were taken by 23 male and 21 female participants accounting for a total of 44%. In addition, 16 
male and 18 female were observed to be taking 3-drug fixed dose combinations representing 
34%. Further, it showed that 9 male (10%) and 4 female (4%) participants respectively, were 
consuming more than three drugs in non-combined formulations. Thus, more participants were 
on fixed dose drug combinations resulting in better ART drug adherence outcomes such as high 
number of participants (35.2 % male & 30.8% female) with undetectable viral loads. However, 
an equal number of 39 participants both gender were observed to have been on fixed dose 
combinations. Vanessa et al (2014) indicated that “there is significant improvement in long-term 
cardiovascular medication (81 %) compared to 46 % participants on single formulation 
medications.” It was noted that a significant 10% male and 4% female participant respectively 
were on single agent drugs. 
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4.1.4  To what extent does duration on ART drugs influence adolescents’ drug adherence? 
Table 4.4:Table showing the duration the participants has been on ART drugs 
Duration (Months) on ART drugs 
 Duration on ART  Gender  Participant 
Less than 30 days (1month) Male 0 
Female 0 
31 to 90 days (1-3 months) Male 0 
Female 1 
91 to 180 days (3-6 months) Male 2 
Female 1 
181 to 360 days (6-11 months) Male 1 
Female 3 
Greater than 361 days (> 12months) Male 46 
Female 39 
 
Figure 4.3.Diagram showing the duration (Months) of participants on ART drugs. 
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Figure 4.3 illustrated that there was not even one participant enrolled on ART care in under 1 
month duration and only one female had taken ART drugs for 3 months only. In a 
progressivetrend participants on ART drugs are demonstrated to be increasingwith over 3 months 
duration observing 2 male and 1 female and then 3 female and 1 male in less than 12 months 
respectively. Subsequently, majority participants wereon treatment above 12 months (39 female 
and 46 male participants) during the study period. Further, it portrayed that more male (46) 
participants were on ART drugs compared to 39 female in the same study population. Thus, the 
majority of the study participants (85) were experiencingmore than 12 months on ART drugs 
hence assessing optimal ART drug adherence outcomes was sufficiently valid. 
4.1.5  How does consistent scheduled attendance influence ART adherence? 
Tables 4.5:Table showing participantsscheduled clinic attendance period in Months 
Participants Clinic Attendance 
Duration of Appointments(Months)  Gender 
Number of 
participants 
1 Male 6 Female 1 
2 Male 1 Female 3 
3 Male 14 Female 23 
4 Male 18 Female 21 
5 Male 4 Female 2 
6 Male 3 Female 6 
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Figure 4.4: Diagram showing relationship between consistent clinic attendance and 
ART drug adherence. 
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4.2  Limitations of the study. 
The study was limited to 15 months commencing 2nd May 2016 to 31st July 2017 among 15-20 
year old adolescents living with HIV/AIDS actively served at CCC-KNH in Nairobi County. 
Inactive participants as well as active but non-ART initiated participants were excluded. Absence 
of participants during school session was overcome the researcher’s request to collect secondary 
data from the clinic’s electronic system assisted by an authorized data clerk. Other challenges 
included access to my supervisor due to unforeseen illness with a systemic predetermined 
graduation timetable. The challenge was overcome unconditional delegation to her colleague for 
supervision and researcher’s consistency in faith and prayers for quickest recovery.  
4.3 Chapter summary. 
The findings analyzed in this chapter indicated that gender was influential on ART drug 
adherence in adolescent participants in this study compared to national adult report 
demonstrating more female on ART than their male counterparts. In addition pill burden, viral 
load measures and clinic attendance were confirmatory indicators of optimal ART drug 
adherence outcomes in combating adolescent HIV/AIDS to achieve the UN 2030 AIDS free 
vision. Thus numbers, figures and tables were adequate visual aid in making objectively rational 
decisions and policy formulation. 
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CHAPTER FIVE 
SUMMARY, RECOMMENDATION AND CONCLUSIONS 
5.0 Introductions. 
This chapter encompassed the finalization of the study where the researcher made summary from 
the findings in relation to the study objectives and research questions. Further the researcher 
drew conclusions that directly informed the recommendation to the beneficiaries in the study 
area. A conclusion that amalgamated entire document to the topic and objectives was carried out. 
Notably, public health goal in ART provision was maximal viral suppression for maximizing 
adolescent population survival rate through use of limited available resources. 
5.1  Summary of findings. 
Objectively, the researcher aimed at assessing ART drug adherence among adolescents aged 15-
20 year within a 15 months period at CCC KNH. With the aid of clear, definite secondary data 
abstraction questionnaire, data was organized and presented into tables and figures to answer 
research questions appropriately. 
5.1.1  Effect of gender on ART drug adherence 
It was observed that more male (52.7%) were on ART treatment than female (42.7%). NACC 
(2016) had however demonstrated that Nairobi County had 6.1% HIV/AIDS prevalence that 
estimated 7.6 % in women and 4.7 % in menand was inference that female gender than men were 
more vulnerable to HIV/AIDS in the city. Thus more boys were on ART drug Adherence due to 
enrolment into ART care by their HIV positive mothers’ prior to teenage year’s contribution 
significantly intomore male on ART drug adherence than female in that age group. 
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5.1.2  Relationship between pill burden and ART drug adherence 
According to patateam (2015) report, adolescent living with HIV/AIDS was rampant globally 
and Kenya and India were listed high. Thus co-morbidities of HIV/AIDS remained key factor in 
adolescent prescription writing. Jeremy and Scotts (2011) advocated for fixed dose drug concept 
to ease pill burden, lower production costs and enhance end-user ease of administration. The 
researcher found out that there were more participants on 2-drugs and 3-drugs fixed dose 
combination than single drugs resulting into many participants with low viral loads and optimal 3 
or 4 months holiday scheduled clinic attendance at CCC KNH 
5.1.3 Viral load as an indicator of ART drug adherence 
According to UNAIDS (2016) virological parameters were modern and most efficient indicator 
of poor ART drug adherence. Further, it highlighted that HIV/AIDS infected person’s immune 
recovery rebound effect was closely witnessed in high viral loads individuals. Thus in adolescent 
participants reports assessed, 60 were confirmed with undetectable VL and 14 maximally 
suppressed. Consequently, only 16 participants demonstrated ART drug poor adherence having 
observed that 13 participants were on single drugs treatment regimen with a possibility of pill 
burden effect. 
5.1.4 Effect of consistent clinic attendance by adolescents 
Sector et al (2010) conducted a study in Kayunga hospital Uganda and confirmed that adherence 
to scheduled clinic was essential in ART drug adherence determination. Unlike children who 
were under the guardianship of parents and appointed caregivers, adolescents assumed 
individualised care which hindered consistency in clinic attendance and prescribed regimen 
actual consumption. It was observed that 3 and 4 months clinic schedules were directly 
influenced by school holiday.  Thus, it was concluded from the findings thatthe participants’ 
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clinic attendance was directly and significantly impacted by adolescent living with HIV/AIDS 
ART drug adherence and individual case clinic tailored follow-up. 
5.2 Recommendations 
The assessment conducted by the researcher recommended that UN 2030 vision to end HIV was 
achievable with intensive, effective and efficient systems on HIV testing and early detection 
ofART treatment failure indicators and adoption of appropriate and timely steps for sustainable 
healthcare youthful population dividends.  
5.2.1   Adolescents / youth and trainings. 
KAIS (2012) indicated that approximately 1.2 Million were persons living with HIV/AIDS. It 
further indicated that only 70 % of adults’ had access to ART drugs. Unlike, children and adults, 
adolescents cannot be treated as small adults or big children in combat against HIV/AIDS 
scourge. The researcher has recommended intensified implementation of adolescents’ friendly 
clinic to foster early HIV testing, status disclosure and enrolment into ART care. It will influence 
both retention and sustainability of the transitioninginfected adolescents into adulthood. ART 
rooted on multi-sector and multi-disciplinary approach for ultimate success. The researcher 
recommends annualsystematic review of adolescent information materials for updates in this 
technology focused era to maintain healthy nation, wealthy nation mantra. Reproductive health, 
life skills and routine post primary education curriculums should be regularly inspected for 
quality age-appropriate information updating on adolescence as well as adolescence living with 
HIV/AIDS. Therefore, appropriate, consistent, age-focused information retainshigh stature in the 
fight against and elimination of adolescence ART drug adherence. 
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5.2.2 Research, development and policy 
Through science based evidence decision making process is made easier and informative. 
Research and development units’responsibility in public, private, academic and business sectors 
is to keep abreast with emergence issues to support policy formulation. HIV/AIDS in adolescents 
is still poorly understood due to its complexity and diversity of considerations in relation to well-
studied adults and children. Thus more collaborative and partnerships are cherished for 
innovative technology and information on dynamic HIV status. This study has provided an 
insight to the fact that there were more adolescent boys than girls living with HIV in Nairobi 
County. Use of accurate secondary data from on-going authentic systems made the findings more 
reliable in follow up specific studies such as adolescent self and community stigma factors or 
trends. These would directly inform on adolescents group policy changes and adoptive training 
in diverse sectors of Nairobi county and national economy. The management of CCC KNH has 
partnered with public, private and independent minded individuals in combating adolescent 
HIV/AIDS scourge. 
5.3 Conclusion. 
Despite three decades on HIV/AIDS studies, no vaccine or cure exist. Thus appropriate use of 
available ART drugs for sustained viral suppression remains paramount. Adolescent HIV/AIDS 
is a ground breaking opportunity to facilitate the UN policy on 2030 AIDS frees generation. This 
assessment study has demonstrated that gender, viral loads, consistent clinic attendance and pill 
burden directly influenced ART drug adherence in adolescent age group within the study period. 
Thus defined role of care givers and guardians and education system in the fight of adolescent 
HIV/AIDS and ART drug adherence cannot be further ignored.  
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APPENDICES 
APPENDIX I:  LETTER OF INTRODUCTION 
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APPENDIX II: DATA ABSTRACTION FORM 
 
1. Participant Date of  Birth  
 
      2.   Participant Age (years) 
 
      3.   Participant Gender:     Male                      Female 
 
      4.   Participant enrolment date on ART drugs 
 
5. Participant ART regimen category: 
                                       3- Drug FDC 
 
                                       2 - Drug FDC 
 
                                        Single Drugs 
 
                                       Any other regimen (specify)    ……………………….. 
 
6.Participant duration on ART since enrolment (days). 
< 30 days 
 90 days 
                                               180 days 
                                               360 days 
>365 days 
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 7.  Participant latest viral load (VL) measures: 
Undetectable VL (< 50 copies/mL) 
 
Suppressed VL (51-999copies/mL) 
 
Not suppressed VL (>1000copies/mL) 
 
8.  Participant clinic attendance schedules dates (Days) 
 
<30 days 
 
  60 days 
 
90 days 
 
120 days 
 
>120 days  
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APPENDIX III: WORK PLAN 
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APPENDIX IV: RESEARCH STUDY BUDGET 
 
ITEM TOTAL COST 
Stationaries 1,500 
Printing 2,500 
Data abstraction & analysis 5,000 
Binding 1,000 
CD drive  100 
Internet research 3,000 
Transport 3,000 
Miscellaneous 1,900 
Total 18,000 
 
